Literature DB >> 8092513

Concentration dependence of lidocaine-induced irreversible conduction loss in frog nerve.

C R Bainton1, G R Strichartz.   

Abstract

BACKGROUND: Concentration is a causal factor in local anesthetic nerve toxicity. Therefore, it is essential to define a concentration below which injury does not occur. We explored the relation of lidocaine concentration and nonreversible block after drug washout in frog sciatic nerve.
METHODS: Frog sciatic nerve was mounted in sucrose-gap or extracellular recording chambers. The observed compound action potential in response to a supramaximal stimulus was used as a measure of nonreversible block after applying lidocaine in a range of concentrations (0.5-200 mM for 15 min) and then washing off (for as long as 180 min).
RESULTS: Lidocaine causes a nonreversible block after washout that begins at concentrations as low as 40 mM and increases in a graded fashion with increasing concentrations to complete ablation of the compound action potential at 80 mM (approximately 2%). Extended storage of frogs (5 weeks) at 4 degrees C makes the nerves more resistant to the effects of lidocaine. The presence of nifedipine (10(-5) M), an L-type calcium-channel blocker, makes the nerves more resistant to lidocaine as well.
CONCLUSIONS: Lidocaine induces a nonreversible loss of impulse activity in frog nerve in a progressive fashion with increasing drug concentration, beginning at 40 mM (approximately 1.0%). The range of lidocaine that produces such changes in mammalian nerve awaits determination.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8092513     DOI: 10.1097/00000542-199409000-00020

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  8 in total

Review 1.  [Toxicology of local anesthetics. Clinical, therapeutic and pathological mechanisms].

Authors:  W Zink; B M Graf
Journal:  Anaesthesist       Date:  2003-12       Impact factor: 1.041

2.  Bacterial meningitis and cauda equina syndrome after epidural steroid injections.

Authors:  A B Cooper; M D Sharpe
Journal:  Can J Anaesth       Date:  1996-05       Impact factor: 5.063

3.  Presentation of Neurolytic Effect of 10% Lidocaine after Perineural Ultrasound Guided Injection of a Canine Sciatic Nerve: A Pilot Study.

Authors:  David D Kim; Asma Asif; Sandeep Kataria
Journal:  Korean J Pain       Date:  2016-07-01

4.  Clinical dose of lidocaine destroys the cell membrane and induces both necrosis and apoptosis in an identified Lymnaea neuron.

Authors:  Shin Onizuka; Ryuji Tamura; Tetsu Yonaha; Nobuko Oda; Yuko Kawasaki; Tetsuro Shirasaka; Seiji Shiraishi; Isao Tsuneyoshi
Journal:  J Anesth       Date:  2011-10-29       Impact factor: 2.078

5.  Tetracaine-membrane interactions: effects of lipid composition and phase on drug partitioning, location, and ionization.

Authors:  Jingzhong Zhang; Theresa Hadlock; Alison Gent; Gary R Strichartz
Journal:  Biophys J       Date:  2007-03-09       Impact factor: 4.033

6.  Effect of chemical permeation enhancers on nerve blockade.

Authors:  Emmanuel J Simons; Evangelia Bellas; Michael W Lawlor; Daniel S Kohane
Journal:  Mol Pharm       Date:  2009 Jan-Feb       Impact factor: 4.939

7.  Local myotoxicity from sustained release of bupivacaine from microparticles.

Authors:  Robert Padera; Evangelia Bellas; Julie Y Tse; Daphne Hao; Daniel S Kohane
Journal:  Anesthesiology       Date:  2008-05       Impact factor: 7.892

8.  Prolongation of greater occipital neural blockade with 10% lidocaine neurolysis: a case series of a new technique.

Authors:  David Daewhan Kim; Nabil Sibai
Journal:  J Pain Res       Date:  2016-09-29       Impact factor: 3.133

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.